4//SEC Filing
EYEGATE PHARMACEUTICALS INC 4
Accession 0001144204-15-053233
$KPRXCIK 0001372514operating
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 4:08 PM ET
Size
7.5 KB
Accession
0001144204-15-053233
Insider Transaction Report
Form 4
HANCOCK THOMAS
Director
Transactions
- Award
Common Stock
2015-08-28+6,519→ 13,487 total - Award
Stock Option (right to buy)
2015-08-28+2,500→ 2,500 totalExercise: $3.59Exp: 2025-08-28→ Common Stock (2,500 underlying)
Footnotes (2)
- [F1]The Reporting Person received Restricted Shares from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Restricted Shares are not subject to vesting.
- [F2]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option became exercisable as to 25% of the shares underlying the Option on August 28, 2015, 25% of the shares underlying the Option become exercisable on August 28, 2016, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeoperating
Related Parties
1- filerCIK 0001372514
Filing Metadata
- Form type
- 4
- Filed
- Aug 31, 8:00 PM ET
- Accepted
- Sep 1, 4:08 PM ET
- Size
- 7.5 KB